| Updates on aptamer research MH Ali, ME Elsherbiny, M Emara International journal of molecular sciences 20 (10), 2511, 2019 | 150 | 2019 |
| The metabolism of amiodarone by various CYP isoenzymes of human and rat, and the inhibitory influence of ketoconazole ME Elsherbiny, AOS El-Kadi, DR Brocks Journal of Pharmacy & Pharmaceutical Sciences 11 (1), 147-159, 2008 | 91 | 2008 |
| Interaction of brain fatty acid-binding protein with the polyunsaturated fatty acid environment as a potential determinant of poor prognosis in malignant glioma ME Elsherbiny, M Emara, R Godbout Progress in lipid research 52 (4), 562-570, 2013 | 69 | 2013 |
| Long-term effect of docosahexaenoic acid feeding on lipid composition and brain fatty acid-binding protein expression in rats ME Elsherbiny, S Goruk, EA Monckton, C Richard, M Brun, M Emara, ... Nutrients 7 (10), 8802-8817, 2015 | 30 | 2015 |
| The ability of polycyclic aromatic hydrocarbons to alter physiological factors underlying drug disposition ME Elsherbiny, DR Brocks Drug metabolism reviews 43 (4), 457-475, 2011 | 30 | 2011 |
| The effect of β-naphthoflavone on the metabolism of amiodarone by hepatic and extra-hepatic microsomes ME Elsherbiny, AOS El-Kadi, DR Brocks Toxicology letters 195 (2-3), 147-154, 2010 | 30 | 2010 |
| A liquid chromatography‐mass spectrometry method for nicotine and cotinine; utility in screening tobacco exposure in patients taking amiodarone RQ Gabr, ME Elsherbiny, V Somayaji, PT Pollak, DR Brocks Biomedical chromatography 25 (10), 1124-1131, 2011 | 21 | 2011 |
| ω-3 and ω-6 fatty acids modulate conventional and atypical protein kinase C activities in a brain fatty acid binding protein dependent manner in glioblastoma multiforme ME Elsherbiny, H Chen, M Emara, R Godbout Nutrients 10 (4), 454, 2018 | 18 | 2018 |
| TLR9: a friend or a foe MM Saber, N Monir, AS Awad, ME Elsherbiny, HF Zaki Life Sciences 307, 120874, 2022 | 16 | 2022 |
| Effects of serum lipoproteins on cyclosporine A cellular uptake and renal toxicity in vitro DR Brocks, HR Chaudhary, M Ben-Eltriki, ME Elsherbiny, AOS El-Kadi Canadian journal of physiology and pharmacology 92 (2), 140-148, 2014 | 16 | 2014 |
| Myoglobin: From physiological roles to potential implications in cancer IE Elkholi, ME Elsherbiny, M Emara Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1877 (3), 188706, 2022 | 15 | 2022 |
| The effect of CYP1A induction on amiodarone disposition in the rat ME Elsherbiny, DR Brocks Journal of pharmaceutical sciences 99 (1), 539-548, 2010 | 10 | 2010 |
| Experimental evidence for diiodohydroxyquinoline-induced neurotoxicity: characterization of age and gender as predisposing factors AS Kamel, AF Mohamed, MA Rabie, ME Elsherbiny, KA Ahmed, ... Pharmaceuticals 15 (2), 251, 2022 | 7 | 2022 |
| Myoglobin variants are expressed in human glioblastoma cells‑hypoxia effect? R El‑Tohamy, I Elkholi, ME Elsherbiny, M Magdy, O Hammam, ... Oncology Reports 43 (3), 975-985, 2020 | 6 | 2020 |
| Expression of myoglobin in normal and cancer brain tissues: correlation with hypoxia markers ME Elsherbiny, M Shaaban, R El-Tohamy, IE Elkholi, OA Hammam, ... Frontiers in Oncology 11, 590771, 2021 | 5 | 2021 |
| Stationary-to-migratory transition in glioblastoma stem-like cells driven by a fatty acid-binding protein 7-RXRα neurogenic pathway RZ Liu, WS Choi, S Jain, X Xu, ME Elsherbiny, DD Glubrecht, AG Tessier, ... Neuro-oncology 25 (12), 2177-2190, 2023 | 4 | 2023 |
| Chrysin promotes angiogenesis in rat hindlimb ischemia: impact on PI3K/Akt/mTOR signaling pathway and autophagy R Kamel, EM El Morsy, ME Elsherbiny, M Nour‐Eldin Drug development research 83 (5), 1226-1237, 2022 | 4 | 2022 |
| Repression of inflammatory pathways with Boswellia for alleviation of liver injury after renal ischemia reperfusion N Monir, MM Saber, AS Awad, ME Elsherbiny, HF Zaki Life Sciences 306, 120799, 2022 | 3 | 2022 |
| Hyperlipidemia: Insights into Mechanisms Involved in Modulation of Drug Pharmacokinetics and Response ME Elsherbiny Egyptian Journal of Basic and Clinical Pharmacology 10, 2020 | 1 | 2020 |
| Assessment of the inactivation potential of desethylamiodarone on human CYP1A1 ME Elsherbiny, AOS El-Kadi, DR Brocks Drug Metabolism Letters 4 (1), 9-14, 2010 | 1 | 2010 |
